IN8bio, Inc.
INAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,854 | -$5,094 | -$5,550 | -$6,160 |
| Dep. & Amort. | $401 | $541 | $669 | $702 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $955 | $831 | $0 |
| Change in WC | -$889 | -$572 | $928 | $605 |
| Other Non-Cash | $818 | $243 | $0 | $825 |
| Operating Cash Flow | -$3,524 | -$3,927 | -$3,122 | -$4,028 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$33 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$33 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$123 | -$234 | -$225 | -$219 |
| Stock Issued | $1,112 | $5,501 | $4,118 | $11,406 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $989 | $5,267 | $3,893 | $11,187 |
| Forex Effect | -$2 | $0 | $0 | -$7 |
| Net Chg. in Cash | -$2,537 | $1,340 | $771 | $7,119 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,226 | $12,157 | $11,386 | $4,001 |
| End Cash | $10,689 | $13,497 | $12,157 | $11,120 |
| Free Cash Flow | -$3,524 | -$3,927 | -$3,122 | -$4,061 |